SPARC mRNA and protein in CML cells from patients at diagnosis was downregulated with respect to healthy controls (HC) (p<0.001 for mRNA and p<0.05 for protein) (Figures 1 and 2b). This evidence concerns the gene SPARC and chronic myelogenous leukemia, BCR-ABL1 positive.